2010
2010

In the month of July, Maven Pharma was founded from the idea of an enterprising pharmacist with years of experience in the galenic sector. From the very beginning, it has relied on the collaboration of a team of executives with thirty years of experience in the pharmaceutical sector. In its early years, Maven Pharma created a series of innovative formulations which, thanks to their proven effectiveness, have managed to carve out an increasingly important role in the healthcare sector.

2013
2013

Maven Pharma acquires the status of ‘Pharmaceutical Company‘, with recognition by the A.I.F.A., having taken a drug concession.

2014
2014

Maven Pharma acquires its first A.I.C., consolidating an already rich catalog of nutraceuticals and medical devices. As a result, Zindel, based on azithromycin dihydrate, becomes part of the Maven Pharma family.

Thanks to continuous efforts and steadily growing revenues, Maven Pharma significantly expands its medical information network, managing to be present in most of the national territory.

2016
2016

In the month of May, Maven Pharma internalizes production, inaugurating a technologically advanced facility in line with the most modern technical-pharmaceutical standards. The idea of creating their own production site was born to break free from the market dynamics followed by almost all companies in the sector, but above all to maximize control capacity and acquire the formulation freedom (selection of raw materials, optimization of formulation, etc.) necessary to guarantee the quality of their products.

The leap in quality is immediately evident; under the supervision of the technical production director, the quality and presentation of the products improve significantly, and the development of new successful formulations is decidedly accelerated.

2019
2019

Having optimized the production process, Maven Pharma acquires a large structure adjacent to the production site, designated for offices, logistics, and a conference room, and focuses on implementing an internal procedures system aimed at refining organization and aiming for increasingly higher standards.
In addition to the medical information line, a commercial line is introduced for direct sales to pharmacies.

 

.

2023
2023

Maven Pharma achieves concrete stability, enabling it to face one of the most turbulent periods in modern history, boasting a sales network throughout the national territory composed of over 70 pharmaceutical sales representatives and 6 area managers.